The 49-year-old said he did not feel unlucky as many others "have it worse".Read the full story ›
Researchers have said preventative measures could 'substantially' reduce the risk.Read the full story ›
"My sincerest apologies to everyone who purchased tickets and were planning to come to the upcoming shows."Read the full story ›
Some Parkinson's sufferers are delaying revealing their diagnosis or hiding their symptoms out of "embarrassment," a study suggests.Read the full story ›
Sir Roger Bannister, the first man to run a four-minute mile, has revealed he has Parkinson's disease.
The 85-year-old former athlete, who went on to have a distinguished medical career, told BBC Radio Oxford he was now "having trouble with walking" because of the disease.
Doctors believe a drug used to treat diabetes could significantly help people suffering from Parkinson's Disease.
Tests on the drug are still in their very early stages, but initial results suggest it might combat aspects of the physical degeneration caused by the disease.
ITV News reporter Ben Chapman reports:
Parkinson's UK have said it is "too soon to know effects" the common diabetes drug Exenatide will have on the treatment of Parkinson's disease.
This new research is a huge step forward in the on-going fight to find a drug which can slow down, or even halt, the progression of Parkinson's.
Despite these encouraging results, it is simply too soon to tell whether this drug is a blind alley or a breakthrough for people with Parkinson's.
The research was conducted in a very small number of people and, crucially, without a placebo group – making it difficult to draw too many firm conclusions at this stage.
We look forward to seeing the results of a much larger trial to fully examine the usefulness of exenatide for people with Parkinson's.
A diabetes drug called Exenatide could be beneficial for the treatment of Parkinson's disease, new research has found.
This new study is perhaps more noteworthy for the approach it has taken with respect to the clinical trial design.
All of this was done in a modest number of patients and the results compared with a matched control arm that received best medical therapy.
Using this approach they found a signal of effect that suggested that the drug may well be slowing down the disease process.
All of which is good news not only for patients with PD but for us all, as we seek to explore how drugs already out there could be repositioned.
A common diabetes drug called Exenatide could be beneficial for the treatment of Parkinson's disease, new research suggests.Read the full story ›
- Although research is ongoing, to date there is no known cure or way to prevent Parkinson's disease.
- Parkinson's disease (PD) is a degenerative neurological disorder marked by a progressive loss of motor control.
- The recent study investigated the use of a drug approved for diabetes care, Exenatide, in PD patients.
- Patients were divided into two groups: 20 patients received Exenatide injections for 12 months, while the other group of 24 patients served as controls.
- After one year of treatment patients receiving Exenatide displayed improved cognitive ability and motor skills, while control patients declined.
- The study suggests that Exenatide may improved motor function in patients and provides a strong rationale for conducting a larger study.
The study was carried out by the Journal of Clinical Investigation.